LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Perspective Therapeutics Inc

Închisă

5.02 3.08

Rezumat

Modificarea prețului

24h

Curent

Minim

4.62

Maxim

5.03

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+152.98% upside

Dividende

By Dow Jones

Următoarele câștiguri

26 mar. 2026

Perspective Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

18 feb. 2026, 22:31 UTC

Câștiguri

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 feb. 2026, 22:18 UTC

Câștiguri

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 feb. 2026, 22:11 UTC

Câștiguri

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 feb. 2026, 21:52 UTC

Câștiguri

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 feb. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 feb. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 feb. 2026, 23:34 UTC

Market Talk
Câștiguri

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 feb. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 feb. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 feb. 2026, 22:45 UTC

Câștiguri

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 feb. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 feb. 2026, 22:37 UTC

Câștiguri

Nutrien 4Q EPS $1.18 >NTR.T

18 feb. 2026, 22:37 UTC

Câștiguri

Nutrien 4Q Sales $5.34B >NTR.T

18 feb. 2026, 22:35 UTC

Câștiguri

Pan American Silver 4Q EPS $1.07 >PAAS

18 feb. 2026, 22:35 UTC

Câștiguri

Pan American Silver 4Q Rev $1.18B >PAAS

18 feb. 2026, 22:30 UTC

Câștiguri

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 feb. 2026, 22:29 UTC

Câștiguri

Kinross Gold 4Q EPS 75c >K.T

18 feb. 2026, 22:22 UTC

Câștiguri

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 feb. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 feb. 2026, 22:16 UTC

Câștiguri

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 feb. 2026, 22:05 UTC

Câștiguri

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 feb. 2026, 22:03 UTC

Câștiguri

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q Sales $929M >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 feb. 2026, 22:00 UTC

Câștiguri

Kinross Gold 4Q Adj EPS 67c >KGC

18 feb. 2026, 22:00 UTC

Câștiguri

Kinross Gold 4Q Sales $2.02B >KGC

18 feb. 2026, 21:56 UTC

Câștiguri

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparație

Modificare preț

Perspective Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

152.98% sus

Prognoză pe 12 luni

Medie 11.89 USD  152.98%

Maxim 18 USD

Minim 4 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerspective Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

11 ratings

10

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

$

help-icon Live chat